Testing PVT401 in healthy volunteers
Part of Digestive system clinical trials.
This study tests a new investigational drug called PVT401 in healthy people. It is a first-in-human study to see how the drug is handled by the body and to check for any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- Your body mass index (BMI) is between 18 and 32
- You have a specific genetic marker called HLA-DRB4*0101 or HLA-DRB4*0103
- You are generally healthy, with no major medical conditions
- You agree to avoid pregnancy and use birth control if needed
- You have not had surgery or donated blood in the past 2 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new tablet medication (called QLS1510) for the first time in people. It is for healthy volunteers to check how the drug is processed by the body and whether it is safe, which helps decide if it can be tested in patients later.
This early-stage study tests a new drug called EQ504 in healthy volunteers to see how safe it is and how the body handles it. Participants receive either the drug or a placebo (inactive substance), and the study helps determine the right dose for future research.
This early-stage study tests a new investigational drug called HW201877 in healthy volunteers. The goal is to see if the drug is safe and how the body processes it.
This study tests a new investigational drug (called LMT503) for the first time in humans, in healthy volunteers. It is a phase 1 trial that will look at how the body processes the drug and its safety, including how it behaves in the blood. The trial involves taking the drug once (single dose) or multiple times over several days, with close monitoring by the research team.
This early-phase trial tests a new drug called SPH7854 granules in healthy people to check how the body processes it and if it's safe. You would take the drug and have regular check-ups.
This study tests a new experimental medicine called IBI3042, given as a single dose, to see how safe it is in healthy volunteers. It is an early-phase trial that helps doctors understand if the drug is well-tolerated before testing it in patients.
Hear when a new Inflammatory Bowel Disease (IBD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.